Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Index by author

December 2021; Volume 41,Issue 12

Special Issue on New Anticancer Agents

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Abe, YUTA

    1. You have access
      Intravenous Administration of Dehydroxymethylepoxyquinomicin With Polymer Enhances the Inhibition of Pancreatic Carcinoma Growth in Mice
      HIROTO FUJISAKI, YUTAKA NAKANO, SACHIKO MATSUDA, KEIICHI SUZUKI, OSAMU ITANO, MASAYUKI TANAKA, SHUTARO HORI, YASUSHI HASEGAWA, YUTA ABE, HIROSHI YAGI, MINORU KITAGO, TOMOHIRO KONNO, KAZUHIKO ISHIHARA, KEIKO OHNO, SATOSHI KISHINO, KAZUO UMEZAWA and YUKO KITAGAWA
      Anticancer Research December 2021, 41 (12) 6003-6012; DOI: https://doi.org/10.21873/anticanres.15419
  2. Acuna, ULYANA MUNOZ

    1. You have access
      Activity in MCF-7 Estrogen-sensitive Breast Cancer Cells of Capsicodendrin from Cinnamosma fragrans
      ULYANA MUNOZ ACUNA, NATHAN EZZONE, L. HARINANTENAINA RAKOTONDRAIBE and ESPERANZA J. CARCACHE DE BLANCO
      Anticancer Research December 2021, 41 (12) 5935-5944; DOI: https://doi.org/10.21873/anticanres.15412
  3. Akimoto, KAZUNORI

    1. You have access
      GLO 1 and PKCλ Regulate ALDH1-positive Breast Cancer Stem Cell Survival
      HITOMI MOTOMURA, SHOMA TAMORI, MASA-AKI YATANI, AYANO NAMIKI, CHOTARO ONAGA, AYAKA OZAKI, RYOKO TAKASAWA, YASUNARI MANO, TSUGUMICHI SATO, YASUSHI HARA, KEIKO SATO, YUYUN XIONG, YOHSUKE HARADA, TAKEHISA HANAWA, SEI-ICHI TANUMA, KAZUNORI SASAKI, SHIGEO OHNO and KAZUNORI AKIMOTO
      Anticancer Research December 2021, 41 (12) 5959-5971; DOI: https://doi.org/10.21873/anticanres.15415
  4. Aoki, HIROSHI

    1. You have access
      Immune Checkpoint Inhibitor as a Therapeutic Choice for Double Cancer: A Case Series
      HIROSHI AOKI, NAOKI MATSUMOTO, HIROSHI TAKAHASHI, MASAYUKI HONDA, TOMOHIRO KANEKO, SHUHEI ARIMA, TOMOTAKA ISHII, TAKU MIZUTANI, RYOTA MASUZAKI, KAZUSHIGE NIREI, HIROAKI YAMAGAMI, MASAHIRO OGAWA, TATSUO KANDA, MITSUHIKO MORIYAMA and KATSUHIRO MIURA
      Anticancer Research December 2021, 41 (12) 6225-6230; DOI: https://doi.org/10.21873/anticanres.15442
  5. Aoki, ICHIO

    1. You have access
      Pharmacological Strategy for Selective Targeting of Glioblastoma by Redox-active Combination Drug – Comparison With the Chemotherapeutic Standard-of-care Temozolomide
      AKIRA SUMIYOSHI, SAYAKA SHIBATA, ZHIVKO ZHELEV, THOMAS MILLER, DESSISLAVA LAZAROVA, GENOVEVA ZLATEVA, ICHIO AOKI and RUMIANA BAKALOVA
      Anticancer Research December 2021, 41 (12) 6067-6076; DOI: https://doi.org/10.21873/anticanres.15426
  6. Arima, SHUHEI

    1. You have access
      Immune Checkpoint Inhibitor as a Therapeutic Choice for Double Cancer: A Case Series
      HIROSHI AOKI, NAOKI MATSUMOTO, HIROSHI TAKAHASHI, MASAYUKI HONDA, TOMOHIRO KANEKO, SHUHEI ARIMA, TOMOTAKA ISHII, TAKU MIZUTANI, RYOTA MASUZAKI, KAZUSHIGE NIREI, HIROAKI YAMAGAMI, MASAHIRO OGAWA, TATSUO KANDA, MITSUHIKO MORIYAMA and KATSUHIRO MIURA
      Anticancer Research December 2021, 41 (12) 6225-6230; DOI: https://doi.org/10.21873/anticanres.15442
  7. Asakage, TAKAHIRO

    1. You have access
      Efficacy and Safety of Induction Chemotherapy and/or External Beam Radiotherapy Followed by Brachytherapy in Patients With Tongue Cancer
      RYO-ICHI YOSHIMURA, KAZUMA TODA, HIROSHI WATANABE, ATSUSHI KAIDA, HIROYUKI HARADA, TAKAHIRO ASAKAGE and MASAHIKO MIURA
      Anticancer Research December 2021, 41 (12) 6259-6266; DOI: https://doi.org/10.21873/anticanres.15446
  8. Asano, TAKAKO

    1. You have access
      The Dual Histone Deacetylase-Proteasome Inhibitor RTS-V5 Acts Synergistically With Ritonavir to Induce Endoplasmic Reticulum Stress in Bladder Cancer Cells
      KAZUKI OKUBO, NINA REßING, WOLFGANG A. SCHULZ, FINN K. HANSEN, TAKAKO ASANO and AKINORI SATO
      Anticancer Research December 2021, 41 (12) 5987-5996; DOI: https://doi.org/10.21873/anticanres.15417
  9. Baba, KAEDE

    1. You have access
      Comparison of Treatment Completion Rate Between Conventional and Dose-dense Doxorubicin and Cyclophosphamide (AC) Followed by a Taxane in Patients With Breast Cancer: A Propensity Score-matched Analysis
      KANAKO MAMISHIN, YOICHI NAITO, SHOGO NOMURA, GAKUTO OGAWA, KUMI NIGUMA, KAEDE BABA, SAEKO SAKAEDA, HIROMICHI NAKAJIMA, SHOTA KUSUHARA, CHIKAKO FUNASAKA, TAKEHIRO NAKAO, YOKO FUKASAWA, CHIHIRO KONDOH, KENICHI HARANO, TAKAHIRO KOGAWA, NOBUAKI MATSUBARA, AKO HOSONO, TOSHIKATSU KAWASAKI and TORU MUKOHARA
      Anticancer Research December 2021, 41 (12) 6217-6224; DOI: https://doi.org/10.21873/anticanres.15441
  10. Bai, QIAN

    1. You have access
      Harnessing the Power of Kiwifruit for Radiosensitization of Melanoma
      LEON KOU, ZIWEN ZHU, EMERSON FAJARDO, QIAN BAI, CHASE REDINGTON, HUAPING XIAO, MARCO LEQUIO, NELSON SHAM, MARK R. WAKEFIELD and YUJIANG FANG
      Anticancer Research December 2021, 41 (12) 5945-5951; DOI: https://doi.org/10.21873/anticanres.15413
« Previous (Pages : 1 2 3 4 5 6 ... 34) Next »
Back to top
PreviousNext

In this issue

Anticancer Research
Vol. 41, Issue 12
December 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Osteosarcoma Patient-derived Orthotopic Xenograft (PDOX) Models Used to Identify Novel and Effective Therapeutics: A Review
  • Effect of Diallyl Trisulfide on TNF-α-induced CCL2/MCP-1 Release in Genetically Different Triple-negative Breast Cancer Cells
  • The Novel, Orally Bioavailable CDK9 Inhibitor Atuveciclib Sensitises Pancreatic Cancer Cells to TRAIL-induced Cell Death
  • The Thioredoxin-1 Inhibitor, PX-12, Suppresses Local Osteosarcoma Progression
  • Reduction in Copper Uptake and Inhibition of Prostate Cancer Cell Proliferation by Novel Steroid-based Compounds
Sign up for alerts
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire